おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Aduro BioTech
company
About
Aduro BioTech is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies.
- 101 - 250
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $51.40M
- Industries
- Biopharma,Biotechnology,Life Science
- Founded date
- Jan 1, 2000
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Aduro Biotech is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies that are designed to harness the body's natural immune system for the treatment of patients with challenging diseases.It was founded in 2000 and headquartered in Berkeley, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$51.40M
Aduro BioTech has raised a total of
$51.40M
in funding over 2 rounds. Their latest funding was raised on
Jan 5, 2015 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 5, 2015 | Series D | $51.40M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Aduro BioTech is funded by 1 investors.
Franklin Advisors
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Franklin Advisors
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
